Trial Result TablesBelow are 3 trial result tables.None of the 3 tables include the phase 1 patients as it looks like Theralase will be presenting trial data without them from now on.
The first is from the ASCO presentation (29 Nov 22 results) but with the phase 1 patients removed.
The second is derived from the AUA presentation table and Swimmer's Plot. It includes the CR patients so that the ASCO results and AUA results can be compared.
The third is the same as the AUA table but with the first 12 undertreated patients removed. I believe this table most accurately reflects the efficacy of the treatment.
| Assessed | 90 Days | 180 Days | 270 Days | 360 Days | 350 Days |
| | % | # | % | # | % | # | % | # | % | # |
| CR | 53% | 21 | 43% | 15 | 38% | 13 | 26% | 8 | 23% | 6 |
| IR | 15% | 6 | 26% | 9 | 21% | 7 | 16% | 5 | 12% | 3 |
| TR | 68% | 27 | 69% | 24 | 59% | 20 | 42% | 13 | 35% | 9 |
| NR | 32% | 13 | 31% | 11 | 41% | 14 | 58% | 18 | 65% | 17 |
| Evaluable | 40 | 35 | 34 | 31 | 26 |
Results from ASCO Presentation minus phase 1 patients | Assessed | 90 Days | 180 Days | 270 Days | 360 Days | 350 Days |
| | % | # | % | # | % | # | % | # | % | # |
| CR | 54% | 28 | 49% | 23 | 38% | 15 | 24% | 9 | 22% | 8 |
| IR | 12% | 6 | 17% | 8 | 15% | 6 | 5% | 2 | 5% | 2 |
| TR | 65% | 34 | 66% | 31 | 53% | 21 | 29% | 11 | 27% | 10 |
| NR | 35% | 18 | 34% | 16 | 47% | 19 | 71% | 27 | 73% | 27 |
| Evaluable | 52 | 47 | 40 | 38 | 37 |
Results from AUA Presentation including CR patients | Assessed | 90 Days | 180 Days | 270 Days | 360 Days | 350 Days |
| | % | # | % | # | % | # | % | # | % | # |
| CR | 70% | 28 | 66% | 23 | 54% | 15 | 35% | 9 | 32% | 8 |
| IR | 15% | 6 | 23% | 8 | 21% | 6 | 8% | 2 | 8% | 2 |
| TR | 85% | 34 | 89% | 31 | 75% | 21 | 42% | 11 | 40% | 10 |
| NR | 15% | 6 | 11% | 4 | 25% | 7 | 58% | 15 | 60% | 15 |
| Evaluable | 40 | 35 | 28 | 26 | 25 |
Results from AUA Presentation including CR patients with the 12 undertreated patients removed